申请人:Takeda Pharmaceutical Company Limited
公开号:US09181249B2
公开(公告)日:2015-11-10
The present invention provides compounds of formula I:
which are useful as modulators of GPR6, pharmaceutical compositions thereof, methods for treatment of conditions associated with GPR6, processes for making the compounds and intermediates thereof.
本发明提供了式I的化合物:它们可用作GPR6调节剂,其制药组合物,用于治疗与GPR6相关疾病的方法,制备该化合物及其中间体的过程。